Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Leukemia
    January 2024
  1. DUARTE TL, Lopes M, Oliveira M, Santos AG, et al
    Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
    Leukemia. 2024;38:96-108.
    >> Share

  2. LI C, Xu J, Luo W, Liao D, et al
    Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
    Leukemia. 2024;38:149-159.
    >> Share

    December 2023
  3. LIU Y, Karlsson S
    Correction: Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia.
    Leukemia. 2023 Dec 13. doi: 10.1038/s41375-023-02101.
    >> Share

    November 2023
  4. LIU Y, Karlsson S
    Perspectives of current understanding and therapeutics of Diamond-Blackan anemia.
    Leukemia. 2023 Nov 16. doi: 10.1038/s41375-023-02082.
    >> Share

  5. BAUER K, Machherndl-Spandl S, Kazianka L, Sadovnik I, et al
    CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
    Leukemia. 2023;37:2250-2260.
    >> Share

    October 2023
  6. FATTIZZO B, Gurnari C, Cassanello G, Bortolotti M, et al
    Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
    Leukemia. 2023 Oct 4. doi: 10.1038/s41375-023-02047.
    >> Share

    August 2023
  7. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2023 Aug 25. doi: 10.1038/s41375-023-02011.
    >> Share

  8. SEKERES MA, Montesinos P, Novak J, Wang J, et al
    Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.
    Leukemia. 2023 Aug 21. doi: 10.1038/s41375-023-02001.
    >> Share

    June 2023
  9. MARION W, Koppe T, Chen CC, Wang D, et al
    RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
    Leukemia. 2023 Jun 30. doi: 10.1038/s41375-023-01945.
    >> Share

  10. GALE RP, Hinterberger W, Young NS, Gennery AR, et al
    What causes aplastic anaemia?
    Leukemia. 2023;37:1191-1193.
    >> Share

    May 2023
  11. NIKITIN E, Kislova M, Morozov D, Belyakova V, et al
    Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
    Leukemia. 2023 May 18. doi: 10.1038/s41375-023-01891.
    >> Share

    February 2023
  12. HUBER S, Haferlach T, Meggendorfer M, Hutter S, et al
    Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
    Leukemia. 2023;37:500-502.
    >> Share

    October 2022
  13. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
    Molecular landscape of immune pressure and escape in aplastic anemia.
    Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
    >> Share

    September 2022
  14. MESA R, Harrison C, Oh ST, Gerds AT, et al
    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
    Leukemia. 2022;36:2261-2268.
    >> Share

    August 2022
  15. KELKKA T, Tyster M, Lundgren S, Feng X, et al
    Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
    Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
    >> Share

    July 2022
  16. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
    Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
    Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
    >> Share

    May 2022
  17. HUANG Y, Chen M, Yang C, Ruan J, et al
    Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
    Leukemia. 2022;36:1351-1360.
    >> Share

  18. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
    Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Leukemia. 2022;36:1432-1435.
    >> Share

    April 2022
  19. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
    >> Share

  20. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
    Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
    Leukemia. 2022;36:1189-1192.
    >> Share

    January 2022
  21. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    >> Share

    October 2021
  22. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    >> Share

    September 2021
  23. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    >> Share

    August 2021
  24. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    >> Share

  25. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    >> Share

    June 2021
  26. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    >> Share

    May 2021
  27. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    >> Share

    April 2021
  28. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    >> Share

  29. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    >> Share

    March 2021
  30. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    >> Share

  31. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    >> Share

  32. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    >> Share

    November 2020
  33. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016